Pdt Partners, LLC Bausch Health Companies Inc. Transaction History

Pdt Partners, LLC

$1.58 Billion
Q2 2025

A detailed history of Pdt Partners, LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 41,845 shares of BHC stock, worth $274,084. This represents 0.02% of its overall portfolio holdings.

Number of Shares

41,845

Holding current value

$274,084

% of portfolio

0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$4.32 - $6.66 $180,770 - $278,687	41,845 New	41,845 $278,000
Q1 2023 May 15, 2023	BUY	$6.28 - $9.85 $529,705 - $830,827	84,348 Added 94.55%	173,559 $1.41 Million
Q4 2022 Feb 14, 2023	SELL	$6.09 - $7.93 $19,749 - $25,716	-3,243 Reduced 3.51%	89,211 $560,000
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $832,625 - $1.67 Million	-181,796 Reduced 66.29%	92,454 $637,000
Q2 2022 Aug 15, 2022	BUY	$7.06 - $23.63 $1.53 Million - $5.11 Million	216,244 Added 372.8%	274,250 $2.29 Million
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $1.25 Million - $1.61 Million	58,006 New	58,006 $1.33 Million
Q4 2020 Feb 16, 2021	SELL	$15.31 - $21.12 $228,119 - $314,688	-14,900 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$14.88 - $20.13 $3.53 Million - $4.77 Million	-237,019 Reduced 94.09%	14,900 $232,000
Q2 2020 Aug 14, 2020	SELL	$13.31 - $20.51 $1.76 Million - $2.71 Million	-132,132 Reduced 34.4%	251,919 $4.61 Million
Q1 2020 May 15, 2020	BUY	$12.98 - $30.25 $710,577 - $1.66 Million	54,744 Added 16.62%	384,051 $5.95 Million
Q4 2019 Feb 14, 2020	BUY	$18.89 - $31.89 $3.85 Million - $6.5 Million	203,690 Added 162.15%	329,307 $9.85 Million
Q3 2019 Nov 14, 2019	BUY	$20.88 - $25.66 $2.62 Million - $3.22 Million	125,617 New	125,617 $2.75 Million

Others Institutions Holding BHC

# of Institutions

252

Shares Held

243M

Call Options Held

2.44M

Put Options Held

8.42M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.37B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account